SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-06-050542
Filing Date
2006-08-02
Accepted
2006-08-02 11:23:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT a06-16987_1sc13ga.htm SC 13G/A 66450
  Complete submission text file 0001104659-06-050542.txt   68429
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MILSTEIN BUILDING GRANTA PARK CAMBRIDGE X0 CB1 6GH
Business Address MILSTEIN BUILDING GRANTA PARK CAMBRIDGE X0 CB1 6GH 44 (0) 1223 471471
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC (Subject) CIK: 0001067386 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79252 | Film No.: 06996730
SIC: 8731 Services-Commercial Physical & Biological Research